These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 6124098)

  • 1. Formation of novel biologically active leukotrienes by omega-oxidation in human leukocyte preparations.
    Lindgren JA; Hansson G; Claesson HE; Samuelsson B
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():53-60. PubMed ID: 6124098
    [No Abstract]   [Full Text] [Related]  

  • 2. New group of leukotrienes formed by initial oxygenation at C-15.
    Rådmark O; Lundberg U; Jubiz W; Malmsten C; Samuelsson B
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():61-70. PubMed ID: 6124099
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukotrienes: a new group of biologically active compounds.
    Samuelsson B; Borgeat P; Hammarström S; Murphy RC
    Adv Prostaglandin Thromboxane Res; 1980; 6():1-18. PubMed ID: 6104416
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid and identification of novel omega-oxidized metabolites in the mouse macrophage.
    Hevko JM; Bowers RC; Murphy RC
    J Pharmacol Exp Ther; 2001 Feb; 296(2):293-305. PubMed ID: 11160610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human polymorphonuclear leukocytes by products derived from the peroxidation of human red blood cell membranes.
    Hall LM; Murphy RC
    Chem Res Toxicol; 1998 Sep; 11(9):1024-31. PubMed ID: 9760276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugated triene metabolites of arachidonic acid derived from dioxygenation at carbon-15: origin from eosinophil and mechanisms of biosynthesis.
    Turk J; Maas RL; Roberts LJ; Brash AR; Oates JA
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():123-32. PubMed ID: 6221514
    [No Abstract]   [Full Text] [Related]  

  • 7. Transformation of 15-hydroperoxy-5,9,11,13-eicosatetraenoic acid into novel leukotrienes.
    Lundberg U; Rådmark O; Malmsten C; Samuelsson B
    FEBS Lett; 1981 Apr; 126(1):127-32. PubMed ID: 7238859
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of 12-hydroxy- and 12-hydroperoxy-5,8,10,14-eicosatetraenoic acids on the synthesis of 5-hydroxy-6,8,11,14-eicosatetraenoic acid and leukotriene B4 in human blood leukocytes.
    Maclouf J; Fruteau de Laclos B; Borgeat P
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():159-62. PubMed ID: 6221520
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of cysteinyl leukotrienes and their metabolites in bile of patients with peroxisomal or mitochondrial beta-oxidation defects.
    Mayatepek E; Ferdinandusse S; Meissner T; Wanders RJ
    Clin Chim Acta; 2004 Jul; 345(1-2):89-92. PubMed ID: 15193981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-hydroxylation of 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid in human polymorphonuclear leukocytes.
    Wong PY; Westlund P; Hamberg M; Granström E; Chao PH; Samuelsson B
    J Biol Chem; 1984 Feb; 259(4):2683-6. PubMed ID: 6421809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid mediators of leukocyte function in immediate-type hypersensitivity reactions.
    Goetzl EJ; Goldman DW; Valone FH
    Kroc Found Ser; 1981; 14():169-82. PubMed ID: 6118398
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of the peroxidation products of 13-hydroxy-gamma-linolenate and 15-hydroxyarachidonate: mechanistic studies on the formation of leukotriene-like diols.
    Rector CL; Stec DF; Brash AR; Porter NA
    Chem Res Toxicol; 2007 Nov; 20(11):1582-93. PubMed ID: 17907784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.
    Mayatepek E; Lehmann WD; Fauler J; Tsikas D; Frölich JC; Schutgens RB; Wanders RJ; Keppler D
    J Clin Invest; 1993 Mar; 91(3):881-8. PubMed ID: 8450067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of leukotriene biosynthesis by acetylenic analogs.
    Sok DE; Han CQ; Pai JK; Sih CJ
    Biochem Biophys Res Commun; 1982 Jul; 107(1):101-8. PubMed ID: 6127073
    [No Abstract]   [Full Text] [Related]  

  • 15. Stereospecific removal of the DR hydrogen atom at the 10-carbon of arachidonic acid in the biosynthesis of leukotriene A4 by human leukocytes.
    Maas RL; Ingram CD; Taber DF; Oates JA; Brash AR
    J Biol Chem; 1982 Nov; 257(22):13515-9. PubMed ID: 6292193
    [No Abstract]   [Full Text] [Related]  

  • 16. Transformation of arachidonic acid in leukocytes. Isolation and structural analysis of a novel dihydroxy derivative.
    Borgeat P; Picard S; Vallerand P; Sirois P
    Prostaglandins Med; 1981 Jun; 6(6):557-70. PubMed ID: 6267638
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of arachidonic acid metabolites through the 12-lipoxygenase pathway in human epidermis by high-performance liquid chromatography and gas chromatography/mass spectrometry.
    Antón R; Abián J; Vila L
    Rapid Commun Mass Spectrom; 1995; Spec No():S169-82. PubMed ID: 8829479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of xenobiotic cooxygenation coupled to prostaglandin H2 biosynthesis.
    Marnett LJ; Bienkowski MJ; Pagels WR; Reed GA
    Adv Prostaglandin Thromboxane Res; 1980; 6():149-51. PubMed ID: 6770592
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacology of the leukotrienes].
    Sirois P; Borgeat P
    J Pharmacol; 1984; 15 Suppl 1():53-68. PubMed ID: 6328128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arachidonic acid metabolism of leukocytes].
    Wang ZR
    Sheng Li Ke Xue Jin Zhan; 1986 Jul; 17(3):250-4. PubMed ID: 3541182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.